Iovance Biotherapeutics appoints Corleen Roche as chief financial officer

7 hours ago 1
  • Iovance Biotherapeutics (NASDAQ:IOVA) has appointed Corleen Roche as chief financial officer, effective August 6th, 2025.
  • IOVA -5.97% premarket to $1.89.
  • Source: Press Release

Recommended For You

More Trending News

Read Entire Article